{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T11:00:29Z","timestamp":1785409229537,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.bone.2003.10.004","type":"journal-article","created":{"date-parts":[[2003,12,2]],"date-time":"2003-12-02T12:08:25Z","timestamp":1070366905000},"page":"344-351","source":"Crossref","is-referenced-by-count":93,"title":["Reduction in PINP, a marker of bone metabolism, with raloxifene treatment and its relationship with vertebral fracture risk"],"prefix":"10.1016","volume":"34","author":[{"given":"J.-Y","family":"Reginster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Zegels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Henrotin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Bruyere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Agnusdei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Collette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2003.10.004_BIB1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2003.10.004_BIB2","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1210\/jc.87.8.3609","article-title":"Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial","volume":"87","author":"Delmas","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2003.10.004_BIB3","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)08827-X","article-title":"Treatment of postmenopausal osteoporosis","volume":"359","author":"Delmas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2003.10.004_BIB4","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archinte.162.10.1140","article-title":"Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis","volume":"162","author":"Maricic","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.bone.2003.10.004_BIB5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006478317173","article-title":"Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial","volume":"65","author":"Cauley","year":"2001","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bone.2003.10.004_BIB6","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.287.7.847","article-title":"Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial","volume":"287","author":"Barrett-Connor","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.bone.2003.10.004_BIB7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0002-9343(01)01124-X","article-title":"Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs","volume":"112","author":"Cummings","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bone.2003.10.004_BIB8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1359\/jbmr.2002.17.1.1","article-title":"Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy","volume":"17","author":"Sarkar","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2003.10.004_BIB9","first-page":"S203","article-title":"BMD changes explains only a fraction of the observed fracture risk reduction in risedronate-treated patients","volume":"11","author":"Watts","year":"2000","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2003.10.004_BIB10","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1002\/sim.984","article-title":"A method to assess the proportion of treatment effect explained by a surrogate endpoint","volume":"20","author":"Li","year":"2001","journal-title":"Stat. Med."},{"key":"10.1016\/j.bone.2003.10.004_BIB11","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s001980200068","article-title":"Biochemical indices of bone turnover and the assessment of fracture probability","volume":"13","author":"Johnell","year":"2002","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2003.10.004_BIB12","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/jbmr.5650111021","article-title":"Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study","volume":"11","author":"Garnero","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2003.10.004_BIB13","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1359\/jbmr.1999.14.9.1614","article-title":"Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study","volume":"14","author":"Garnero","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2003.10.004_BIB14","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1210\/jc.82.6.1904","article-title":"The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation","volume":"82","author":"Rosen","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2003.10.004_BIB15","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1359\/jbmr.1998.13.9.1431","article-title":"Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial","volume":"13","author":"Greenspan","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2003.10.004_BIB16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S8756-3282(98)00044-1","article-title":"Changes in biochemical markers and bone mass after withdrawal of ibandronate treatment: prediction of bone mass changes during treatment","volume":"22","author":"Ravn","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.bone.2003.10.004_BIB17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1359\/jbmr.2002.17.2.341","article-title":"Bone histomorphometric and biochemical marker results of a two-year placebo controlled trial of raloxifene in postmenopausal women","volume":"17","author":"Ott","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2003.10.004_BIB18","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1007\/s001980170020","article-title":"Six and twelve month changes in bone turnover are related to reduction in vertebral fracture risk during 3 years of raloxifene treatment in postmenopausal osteoporosis","volume":"12","author":"Bjarnason","year":"2001","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2003.10.004_BIB19","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jbmr.5650110716","article-title":"Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis","volume":"11","author":"Genant","year":"1996","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2003.10.004_BIB20","volume":"vol. 57","author":"Efron","year":"1993"},{"key":"10.1016\/j.bone.2003.10.004_BIB21","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1359\/jbmr.1999.14.8.1404","article-title":"Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures","volume":"14","author":"Bauer","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2003.10.004_BIB22","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1359\/jbmr.1999.14.9.1583","article-title":"The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial","volume":"14","author":"Marcus","year":"1999","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2003.10.004_BIB23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/clinchem\/42.6.947","article-title":"Immunoassay for intact amino-terminal propeptide of human type I procollagen","volume":"42","author":"Melkko","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1016\/j.bone.2003.10.004_BIB24","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S8756-3282(98)00126-4","article-title":"Serum levels of cross-linked N-telopeptides and amino terminal propeptides of type I collagen indicate low bone mineral density in elderly women","volume":"23","author":"Scariano","year":"1998","journal-title":"Bone"},{"key":"10.1016\/j.bone.2003.10.004_BIB25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/003655102317475506","article-title":"Diagnostic efficacy of serum cross-linked N-telopeptide (NTx) and aminoterminal procollagen extension propeptide (PINP) measurements for identifying elderly women with decreased bone mineral density","volume":"62","author":"Scariano","year":"2002","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bone.2003.10.004_BIB26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/PL00004183","article-title":"Differences in the capacity of several biochemical bone markers to assess high bone turnover in early menopause and response to alendronate therapy","volume":"11","author":"Fink","year":"2000","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2003.10.004_BIB27","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/bjc.1998.471","article-title":"Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients","volume":"78","author":"Saarto","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bone.2003.10.004_BIB28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1046\/j.1365-2362.1996.2000550.x","article-title":"Effects of low- and conventional-dose transcutaneous HRT over 2 years on bone metabolism in younger and older postmenopausal women","volume":"26","author":"Sharp","year":"1996","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.bone.2003.10.004_BIB29","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1359\/jbmr.1998.13.7.1124","article-title":"Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability","volume":"13","author":"Hannon","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2003.10.004_BIB30","first-page":"521","article-title":"Reduction in bone turnover predicts hip, non-spine, and vertebral fracture in alendronate treated women: the Fracture Intervention Trial","volume":"13","author":"Bauer","year":"2002","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2003.10.004_BIB31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s001980070089","article-title":"Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men","volume":"11","author":"Fall","year":"2000","journal-title":"Osteoporos. Int."},{"issue":"Suppl 6","key":"10.1016\/j.bone.2003.10.004_BIB32","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001980070002","article-title":"The use of biochemical markers of bone turnover in osteoporosis. Committee of scientific advisors of the international osteoporosis foundation","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2003.10.004_BIB33","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1359\/jbmr.2003.18.6.1051","article-title":"Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate","volume":"18","author":"Eastell","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2003.10.004_BIB34","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archinte.162.6.665","article-title":"Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) safety follow-up study","volume":"162","author":"Greendale","year":"2002","journal-title":"Arch. Intern. Med."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328203003818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328203003818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T14:08:56Z","timestamp":1585318136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328203003818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S8756328203003818"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2003.10.004","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}